Riscoe MK - Search Results

1

ELQ-331 as a prototype for extremely durable chemoprotection against malaria.

Smilkstein MJ, Pou S, Krollenbrock A, Bleyle LA, Dodean RA, Frueh L, Hinrichs DJ, Li Y, Martinson T, Munar MY, Winter RW, Bruzual I, Whiteside S, Nilsen A, Koop DR, Kelly JX, Kappe SHI, Wilder BK, Riscoe MK. Smilkstein MJ, et al. Among authors: riscoe mk. Malar J. 2019 Aug 27;18(1):291. doi: 10.1186/s12936-019-2921-9. Malar J. 2019. PMID: 31455339 Free PMC article.

2

Affinity purification of 5-methylthioribose kinase and 5-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Klebsiella pneumoniae [corrected].

Cornell KA, Winter RW, Tower PA, Riscoe MK. Cornell KA, et al. Among authors: riscoe mk. Biochem J. 1996 Jul 1;317 ( Pt 1)(Pt 1):285-90. doi: 10.1042/bj3170285. Biochem J. 1996. PMID: 8694776 Free PMC article.

3

Potentiation of the antimalarial agent rufigallol.

Winter RW, Cornell KA, Johnson LL, Ignatushchenko M, Hinrichs DJ, Riscoe MK. Winter RW, et al. Among authors: riscoe mk. Antimicrob Agents Chemother. 1996 Jun;40(6):1408-11. doi: 10.1128/AAC.40.6.1408. Antimicrob Agents Chemother. 1996. PMID: 8726010 Free PMC article.

4

Xanthones as antimalarial agents; studies of a possible mode of action.

Ignatushchenko MV, Winter RW, Bächinger HP, Hinrichs DJ, Riscoe MK. Ignatushchenko MV, et al. Among authors: riscoe mk. FEBS Lett. 1997 Jun 2;409(1):67-73. doi: 10.1016/s0014-5793(97)00405-5. FEBS Lett. 1997. PMID: 9199506 Free article.

5

Potentiation of an antimalarial oxidant drug.

Winter RW, Ignatushchenko M, Ogundahunsi OA, Cornell KA, Oduola AM, Hinrichs DJ, Riscoe MK. Winter RW, et al. Among authors: riscoe mk. Antimicrob Agents Chemother. 1997 Jul;41(7):1449-54. doi: 10.1128/AAC.41.7.1449. Antimicrob Agents Chemother. 1997. PMID: 9210664 Free PMC article.

6

Xanthones as antimalarial agents: stage specificity.

Ignatushchenko MV, Winter RW, Riscoe M. Ignatushchenko MV, et al. Am J Trop Med Hyg. 2000 Jan;62(1):77-81. doi: 10.4269/ajtmh.2000.62.77. Am J Trop Med Hyg. 2000. PMID: 10761728

7

A spectroscopic investigation of the binding interactions between 4,5-dihydroxyxanthone and heme.

Xu Kelly J, Winter R, Riscoe M, Peyton DH. Xu Kelly J, et al. J Inorg Biochem. 2001 Sep;86(2-3):617-25. doi: 10.1016/s0162-0134(01)00217-3. J Inorg Biochem. 2001. PMID: 11566335

8

Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

Kelly JX, Winter R, Peyton DH, Hinrichs DJ, Riscoe M. Kelly JX, et al. Antimicrob Agents Chemother. 2002 Jan;46(1):144-50. doi: 10.1128/AAC.46.1.144-150.2002. Antimicrob Agents Chemother. 2002. PMID: 11751125 Free PMC article.

9

The kinetics of uptake and accumulation of 3,6-bis-omega-diethylamino-amyloxyxanthone by the human malaria parasite Plasmodium falciparum.

Kelly JX, Winter RW, Cornea A, Peyton DH, Hinrichs DJ, Riscoe M. Kelly JX, et al. Mol Biochem Parasitol. 2002 Aug 7;123(1):47-54. doi: 10.1016/s0166-6851(02)00118-4. Mol Biochem Parasitol. 2002. PMID: 12165388

10

Antileishmanial drug development: exploitation of parasite heme dependency.

Kelly JX, Ignatushchenko MV, Bouwer HG, Peyton DH, Hinrichs DJ, Winter RW, Riscoe M. Kelly JX, et al. Mol Biochem Parasitol. 2003 Jan;126(1):43-9. doi: 10.1016/s0166-6851(02)00248-7. Mol Biochem Parasitol. 2003. PMID: 12554083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page